Molecular analysis of genetic mutations among cross-resistant second-line injectable drugs reveals a new resistant mutation in Mycobacterium tuberculosis

2016

Lesibana Malinga received PhD funding from National Research foundation (Innovation Fund) and University of Pretoria.

Keywords:

References

Citations